Home ProductsSuppliersNews ServiceContact usAbout us Sign InJoin FreeTrade shows
Welcome to TradingChem
Current position:Home > Products > Ethofumesate

CAS No.:26225-79-6

Name: Ethofumesate

Details Introduction

TOXICITY DATA with REFERENCE:

 


Consensus Reports:The Journal of Clinical Sleep Medicine published a paper which had carried out a systematic review of the medical literature concerning insomnia medications including Eszopiclone. The review found that almost all trials of sleep disorders and drugs are sponsored by the pharmaceutical industry. It was found that the odds ratio for finding results favorable to industry in industry-sponsored trials was 3.6 times higher than non-industry-sponsored studies. The paper found that there is little research into hypnotics that is independent from the drug manufacturers. The author was concerned that there is no discussion of adverse effects of sedative hypnotics discussed in the medical literature such as significant increased levels of infection, cancers and increased mortality in Eszopiclone and other sedative hypnotic drugs and an overemphasis on the positive effects. The author concluded by stating that "major hypnotic trials are needed to more carefully study potential adverse effects of hypnotics such as daytime impairment, infection, cancer, and death and the resultant balance of benefits and risks."[21]
SAFETY PROFILE:

 


Related Searches

Urgent Purchase
About us | Contact us | Service | Link | Make Me Home Page | Add to favorite|Chemical industry exhibitions |Sitemap
Copyright 2010 TradingChem Group Ltd.
All Rights Reserved. No Unauthorized Reproduction or Duplication of Any Kind.
Zhejiang 16009103